Today's Top 20 Gastroenterology and Endoscopy Stories
-
Exact Sciences posts $296M in Q4 revenues — 5 quotes on the company's future
Exact Sciences posted fourth-quarter 2019 revenues of $295.6 million and full-year revenues of $876.3 million. - 2/12/20 -
Dr. Reddy's Laboratories to acquire branded generics business in India
Dr. Reddy's Laboratories will acquire select divisions of Wockhardt Limited's branded generics business in India, Nepal, Sri Lanka, Bhutan and Maldives. - 2/12/20 -
10 reasons text reminders can be a GI recall program game-changer
Statistics show that about one in three of U.S. adults ages 50-75 are not getting screened for colorectal cancer as recommended. - 2/11/20 -
Ohio hospital opens gastroenterology center — 3 insights
Mercy Health-Lorain (Ohio) Hospital opened a gastroenterology center in a vacant space in the facility, The Chronicle reports. - 2/11/20 -
5 gastroenterology trends to know & 4 other must-read articles
Five must read articles for gastronterologists this week: - 2/10/20 -
The rise of Cologuard — Tracking Exact Sciences' journey
Exact Sciences' multitarget stool DNA test, Cologuard, is divisive. Touting 92 percent sensitivity and 87 percent specificity rates for detecting all stages of colorectal cancer, the test is heavily marketed and has seen significant growth recently. - 2/10/20 -
Colorectal cancer task force updates guidelines for colonoscopy follow-up — 3 insights
The U.S. Multi-Society Task Force on Colorectal Cancer updated its 2012 recommendations for postcolonoscopy follow-up with or without polypectomy, according to an article in Gastroenterology Consultant. - 2/10/20 -
4 gastroenterology leaders on the move
Here are four GI leaders who have joined new organizations in the past year: - 2/10/20 -
3 gastroenterologists making headlines
Three gastroenterologists making headlines this week: - 2/7/20 -
Apollo Global Management acquiring Covis Pharma — 3 insights
Affiliates of Apollo Global Management will acquire Covis Pharma BV from Cerberus Capital Management, with a planned closing date in the first quarter of 2020. - 2/7/20 -
The 'epidemic of the 21st century' — Why nonalcoholic steatohepatitis is one of the largest issues in GI today
Nonalcoholic steatohepatitis is a 21st century epidemic that has no simple diagnostic tool or treatment, Medscape reports. - 2/7/20 -
3 leaders in gastroenterology to know
Three gastroenterology leaders to know this week: - 2/6/20 -
New York endoscopy center shifts ownership
The Endoscopy Center of WNY in Williamsville, N.Y, is changing ownership, according to Buffalo Business First. - 2/6/20 -
Lowering the CRC screening age to 45: Pros and cons
Two leading gastroenterologists debated colorectal cancer screening at the 2020 Gastrointestinal Cancers Symposium, Jan. 23-25 in San Francisco, as reported by Targeted Oncology. - 2/6/20 -
Smart Medical launches new colonoscope in European market — 3 insights
Smart Medical Systems is bringing its Smart G-Eye 760R colonoscope to Europe through a partnership with Fujifilm. - 2/6/20 -
Nurse navigators increase CRC screening completion rates, study says
Nurse navigators increased the chances of patients completing colorectal cancer screenings, Clinical Advisor reports. - 2/6/20 -
10 colonoscopy, endoscopy developments for ASC leaders to know
Here is a roundup of the top news relating to colonoscopies and endoscopies from the past year: - 2/5/20 -
Hospital revenue from GIs rose 100%+ in 4 years: 3 report details
Gastroenterology remains a high earning specialty for both physicians and hospitals, according to the 2019 inpatient/outpatient revenue survey from physician search firm Merritt Hawkins. - 2/5/20 -
FDA questions Takeda & more: 5 GI industry key notes
Here are five updates from gastroenterology companies and practices from the past week: - 2/5/20 -
Surveillance colonoscopy possibly prevented 30% of CRC cases, study says
Researchers attempted to quantify the effect surveillance colonoscopy had on colorectal cancer prevention in a study published in Clinical Gastroenterology and Hepatology. - 2/5/20